Lessons from the "Euro-Lupus Cohort"

Annales de Medecine Interne

Volumn 153, Issue 8, 2002, Pages 530-536

  Cervera, Ricard ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Epidemiology; Morbidity; Mortality; Prognostic factors; Systemic lupus erythematosus

Indexed keywords

COHORT ANALYSIS; CONFERENCE PAPER; EUROPE; HUMAN; LUPUS ERYTHEMATOSUS; MORBIDITY; MORTALITY; PROGNOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIBODIES, ANTINUCLEAR; COHORT STUDIES; EUROPE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036971338     PISSN: 0003410X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. CERVERA R: European Working Party on Systemic Lupus Erythematosus: Objectives and projects. Lupus, 1992; 1 (suppl 1): 29.
2. CERVERA R, KHAMASTHA MA, FONT J, et al.: Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. Medicine (Baltimore), 1993; 72: 113-24.
3. CERVERA R, KHAMASTHA MA, FONT J, et al.: Morbidity and mortality in systemic lupus erythematosus. A multicenter prospective study of 1,000 patients. Medicine (Baltimore), 1999; 78: 167-75.
4. GALEAZZI M, MOROZZI G, SEBASTIANI GD, et al.: Antineutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: Prevalence, clinical associations and correlation with other autoantibodies. Clin Exp Rheumatol, 1998; 16: 541-6.
5. GALEAZZI M, BELLISAI F, SEBASTIANI GD, et al.: Association of 16/6 and SA1 anti-DNA idiotypes with anticardiolipin antibodies and clinical manifestations in a large cohort of SLE patients. Clin Exp Rheumatol, 1998; 16: 717-20.
6. SEBASTIANI GD, GALEAZZI M, TINCANI A, et al.: Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Scand J Rheumatol, 1999; 28: 344-51.
7. GALEAZZI M, ANNUNZIATA P, SEBASTIANI GD, et al.: Antiganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: Clinical, serological, and HLA class II gene associations. J Rheumatol, 2000; 27: 135-41.
8. GALEAZZI M, SEBASTIANI GD, TINCANI A, et al.: HLA class II alleles associations of anti-cardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Lupus, 2000; 9: 47-55.
9. HOUSSIAU F, VASCONCELOS C, DE RAMÓN E, et al.: A lowdose IV cyclophosphamide therapy, followed by azathioprine is as effective as high-dose regimen in inducing initial short-term response in proliferative lupus nephritis. Arthritis Rheum, 1997; 40 (suppl): S324.